ArticleInternational journal of clinical oncology2026
Proteinuria as the cause of early dose modification in Japanese patients with metastatic colorectal cancer treated with fruquintinib: a multicenter real-world study.
Shohei Udagawa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.